Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.144
-0.156 (-12.02%)
Apr 28, 2026, 10:30 AM EST
Nuo Therapeutics Revenue
In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth. Nuo Therapeutics had revenue of $1.10M in the quarter ending December 31, 2025, with 177.77% growth.
Revenue
3.31M
Revenue Growth
+142.72%
P/S Ratio
16.71
Revenue / Employee
331.35K
Employees
10
Market Cap
55.36M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 47.48M |
| Harvard Apparatus Regenerative Technology | 704.00K |
| Arch Biopartners | 115.29K |
| Provectus Biopharmaceuticals | 336.11K |
| Vaxart | 237.26M |
Nuo Therapeutics News
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 3 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire